Gastric cancer with brain metastasis and the role of human epidermal growth factor 2 status.

about

Gastric cancer with brain metastasis and the role of human epidermal growth factor 2 status.

Item

http://www.wikidata.org/entity/Q55279544

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Gastric cancer with brain meta ...... dermal growth factor 2 status.

@en

Gastric cancer with brain meta ...... dermal growth factor 2 status.

@nl

type

Item

label

Gastric cancer with brain meta ...... dermal growth factor 2 status.

@en

Gastric cancer with brain meta ...... dermal growth factor 2 status.

@nl

prefLabel

Gastric cancer with brain meta ...... dermal growth factor 2 status.

@en

Gastric cancer with brain meta ...... dermal growth factor 2 status.

@nl

P1476

Gastric cancer with brain meta ...... dermal growth factor 2 status.

@en

P2093

Adriano Zangrandi

http://www.w3.org/2001/XMLSchema#string

Camilla Di Nunzio

http://www.w3.org/2001/XMLSchema#string

Chiara Citterio

http://www.w3.org/2001/XMLSchema#string

Elena Orlandi

http://www.w3.org/2001/XMLSchema#string

Elisa Maria Stroppa

http://www.w3.org/2001/XMLSchema#string

Emanuele Michieletti

http://www.w3.org/2001/XMLSchema#string

Luigi Cavanna

http://www.w3.org/2001/XMLSchema#string

Patrizia Mordenti

http://www.w3.org/2001/XMLSchema#string

Pietro Seghini

http://www.w3.org/2001/XMLSchema#string

Stefano Vecchia

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Gastric cancer and metastasis to the brain.

Multifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer: epidemiological and clinical data from a population-based cancer registry study.

CNS metastases in breast cancer.

Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.

The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature

Brain metastases: the HER2 paradigm.

The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine.

Epidemiologic Study of Human Epidermal Growth Factor Receptor 2 Expression in Advanced/Metastatic Gastric Cancer: an Assessment of Human Epidermal Growth Factor Receptor 2 Status in Tumor Tissue Samples of Gastric and Gastro-Esophageal Junction Canc

Gastrointestinal cancer and brain metastasis: a rare and ominous sign.

P304

5787-5791

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.8054

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29552209

http://www.w3.org/2001/XMLSchema#string

P932

5840578

http://www.w3.org/2001/XMLSchema#string